PROM Detail

Home PROM Detail
Impact of Cancer Scale v2
  • Basic Information
  • Detailed Information
  • Domains
  • Psychometrics

Basic Information

Abbreviated name
IOCv2
Full name
Impact of Cancer Scale v2
Items ?
The number of questions in the survey
37+10
Short description
The IOC was developed specifically to measure unique and multidimensional aspects of long-term cancer survivorship focusing almost exclusively on problems, issues, and changes that long-term survivors ascribe to their cancer experience. Cancer survivorship is defined as a period of 5 years or more post-diagnosis.
PCCC or QoL? ?
This compendium contains patient-reported measures that are either designed to specifically measure aspects of Person Centred Co-Ordinated Care (P3C), or alternatively tools that are designed to measure some aspect of Quality of Life (QoL) or Health Related Quality of Life (hrQoL). All the measures in this compendium have been broadly categorised into one of those two concepts.
Quality of Life
Main Domains Measured ?
This is the key domains that the measure is targeting.
Quality of Life in Cancer
Type of measure ?
The measures in this compendium can take a variety of forms. Generally, they will be either Patient Reported Outcome Measure (PROM) or Patient Reported Experience Measure (PREM). However, we have also included a few measures that are completed by proxy-individual (PROXY), which are useful in instances where the respondent cannot answer directly (e.g. dementia or end of life). Sometimes, these measures can even be a composite of these types, and target both experiences and outcomes – we have labelled these measures “PROEMs”.
PROM
Respondent ?
The person that fills in the questionnaire - e.g. patient, Health Care Professional, or proxy (normally a carer or family member)
Patients

Detailed Information

Year developed ?
The year in which the measure was first published.
2008
Country developed in ?
The main country[s] in which the measure was first developed.
US
Original publication ?
The publication in which the measure was originally published.
Search Citations of Original Reference
http://www.ncbi.nlm.nih.gov/pubmed/18957678
Target condition ?
The measures can be either generic or disease specific (e.g. Diabetes, Heart Failure)
Cancer
Main context tested in ?
The main context in which the measure has been developed and used (E.g. Hopital, General Practice etc).
Cancer survivor follow-up
Main countries used in ?
The main countries in which the measure has been developed and used.
US
Target age ?
e.g. Adults, Children, Elderly
Adults
Main uses of measure ?
The context in which the measure is most often used – e.g. clinical trials; national surveys.
Cancer survivor follow-up care.
Used in UK? ?
Whether the instrument has been tested and validated within a UK healthcare context.
No
Impact ?
A crude indication of the impact of the measure on academia. This is the number of times the original publication has been cited on PubMed, divided/normalised to the years since publication.
2.25
Language
English

Domains

Domain description
Domains include; the meaning attributed to cancer, health awareness and health worries, body image concerns, cancer interference in social life, personal self-evaluation, life outlook and pro-social behaviours (i.e., altruism, empathy), body change concerns, life interferences, positive self-evaluation, altruism/empathy

Psychometrics

Brief description ?
A brief description of the initially reported psychometric properties of the measure.
Internal consistency: Cronbachs alpha was between 0.75 and 0.93 for each factor.